Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Intangibles (2019 - 2025)

X4 Pharmaceuticals (XFOR) has disclosed Intangibles for 3 consecutive years, with $9.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Intangibles changed N/A year-over-year to $9.4 million, compared with a TTM value of $9.4 million through Sep 2025, changed N/A, and an annual FY2024 reading of $10.0 million, changed N/A over the prior year.
  • Intangibles was $9.4 million for Q3 2025 at X4 Pharmaceuticals, down from $9.6 million in the prior quarter.
  • Across five years, Intangibles topped out at $10.0 million in Q4 2024 and bottomed at $9.4 million in Q3 2025.